Cart: 0,00€
X Isuu Mastodon Tiktok
  • Free Shipping for all Order of 36,30€ Spain
Cart: 0,00€

PROSPERA BIOTECH obtains financing for Oncapsisens®

Prospera Biotech has obtained funding for its flagship product, Oncapsisens®, a moisturizing formulation aimed at reducing skin sensitivity caused by oncological treatments such as chemotherapy, which could improve patients' quality of life during therapy.

PROSPERA BIOTECH obtains financing for Oncapsisens® PROSPERA BIOTECH obtains financing for Oncapsisens®


Innovation in the field of biotechnology has led to developments that not only address diseases, but also improve the quality of life of patients during treatments. In this context, Prospera Biotech, a spin-off of the Science Park of the Miguel Hernández University (UMH) of Elche, has managed to obtain financing for its star product, Oncapsisens®.

This moisturizing formulation aims to mitigate skin sensitivity caused by oncological treatments such as chemotherapy.

The company has closed a financing round of 600,000 euros through the Capital Cell crowdfunding platform, exceeding its initial objective and obtaining more than 625,000 euros in investments.

The primary purpose of this funding is to support an international trial examining the effectiveness of Oncapsisens® in protecting against the side effects of chemotherapy, especially induced Peripheral Neuropathy, which affects a large proportion of patients.

This initiative highlights the importance of developing specific solutions that alleviate the discomfort associated with these treatments, allowing patients to continue their therapy optimally and improve their quality of life during the recovery process.

Congratulations from to Prospera Biotech for the success in obtaining financing for Oncapsisens®! Their dedication and work in developing innovative solutions to improve the quality of life of patients during oncological treatments are worthy of recognition. This achievement represents a significant step toward alleviating the discomfort associated with chemotherapy and demonstrates their commitment to the health and well-being of the community. Congratulations on this important milestone and for the positive impact you are generating in the field of biotechnology!


related products

Reviews de PROSPERA BIOTECH obtains financing for Oncapsisens®

Related Manufacturers / Laboratories

Related Categories

By clicking on 'accept all cookies', you accept that cookies are stored on your device to improve site navigation, analyze its use, and collaborate with our marketing studies.
Cookie Settings
Accept all cookies

Privacy Preference Center

When you visit any website, it may collect or store information on your browser, generally through the use of cookies. This information may be about you, your preferences, or your device, and is used primarily to make the site work as expected. The information generally does not directly identify you, but it can provide you with a more personalized web experience. Because we respect your right to privacy, you can choose not to allow us to use certain cookies. Click on each category heading to learn more and change our default settings. However, blocking some types of cookies may affect your experience on the site and the services we can offer.

[Cookies Policy] [More information]

Allow them all

Manage consent preferences

Strictly necessary cookies Always active

These cookies are necessary for the website to function and cannot be disabled in our systems. They are usually configured to respond to actions you take to receive services, such as adjusting your privacy preferences, logging into the site, or filling out forms. You can set your browser to block or alert the presence of these cookies, but some parts of the website will not work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so that we can measure and improve the performance of our site. They help us to know which pages are the most or least popular, and to see how many people visit the site. All the information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you visited our site, and therefore we will not be able to know when you visited it.

Functionality Cookies

These cookies allow the site to offer better functionality and personalization. They may be set by us or by third parties whose services we have added to our pages. If you do not allow these cookies some of our services will not work properly. It also enables storage related to security, such as authentication functionality, fraud prevention, and other user protection.

Targeted cookies

These cookies may be throughout the website, placed by our advertising partners. These businesses may use them to build a profile of your interests and show you relevant ads on other sites. They do not store personal information directly, but are based on the unique identification of your browser and Internet access device. If you do not allow these cookies, you will have less targeted advertising.

Social network cookies

These cookies are set by a number of social networking services that we have added to the site to allow you to share our content with your friends and networks. They are able to track your browser across other sites and create a profile of your interests. This may modify the content and messages you find on other web pages you visit. If you do not allow these cookies you will not be able to see or use these sharing tools.

Confirm my preferences